Shares of rival Novo Nordisk rose as both companies develop weight loss pills.
Topline Shares of Eli Lilly plummeted 14% on Thursday, pacing what would be the stock’s largest loss in decades after the pharmaceutical giant unveiled data for its obesity treatment pill that fell behind Wall Street’s expectations. Shares of rival N... [3089 chars]